B Douglas Ward

Title: The Innovative Mind of B Douglas Ward: Revolutionizing Tumor Measurement Techniques

Introduction: B Douglas Ward, an accomplished inventor based in West Allis, Wisconsin, has made significant contributions to the field of medical imaging. His notable patent focuses on an innovative MRI method that enhances the measurement of tumor hemodynamic parameters, particularly in the context of contrast agent extravasation. This advancement has the potential to improve the understanding of tumor angiogenesis and ultimately aid in cancer treatment.

Latest Patents: B Douglas Ward holds a patent for an "MRI method for measuring tumor hemodynamic parameters in the presence of contrast agent extravasation." This patent addresses a critical challenge in oncology by utilizing an EPI pulse sequence to acquire time course NMR data, allowing for the calculation of T* relaxation rates for gradient echo and T relaxation rates for spin-echo signals. By correcting for contrast agent extravasation, this method facilitates the generation of hemodynamic parameter maps vital for assessing tumor angiogenesis.

Career Highlights: B Douglas Ward is associated with the MCW Research Foundation, Inc., where he employs his expertise in MRI technology to drive innovation in medical research. His work has contributed significantly to advancements in imaging techniques, which can lead to more accurate diagnoses and treatments for cancer patients.

Collaborations: Throughout his career, B Douglas Ward has collaborated with esteemed colleagues, including Kathleen M Schmainda and Christopher Quarles. These collaborations have fostered a productive research environment, enabling the exploration of new methodologies and the advancement of medical imaging technologies.

Conclusion: B Douglas Ward's contributions to the field of medical imaging, particularly through his innovative MRI method, exemplify the impact of invention on healthcare. His dedication to improving tumor measurement techniques not only enhances scientific understanding but also holds promise for better patient outcomes in cancer treatment. As he continues to work with leading researchers at the MCW Research Foundation, his future endeavors are expected to harness even greater innovations in the realm of medical imaging.